The author and colleagues reply: Bueno


Dimopoulos MA, Sonneveld P, Sun H. The author and colleagues reply: Bueno. New England Journal of Medicine [Internet]. 2016;375(25):2497 - 2498.


Export Date: 18 February 2017References: Murphy, M.F., Dumont, L.J., Greinacher, A., Interference of new drugs with compatibility testing for blood transfusion (2016) N Engl J Med, 375, pp. 295-296;(2016) Summary of Product Characteristics: DARZALEX 20 mg/mL Concentrate for Solution for Infusion, ,, London: European Medicines Agency; Regan, D.M., Markowitz, M.A., Mitigating the anti-CD38 interference with serologic testing (2016) AABB Bulletin #16-02, , Bethesda, MD:American Association of Blood Banks; Palumbo, A., Chanan-Khan, A., Weisel, K., Daratumumab, bortezomib, and dexamethasone for multiple myeloma (2016) N Engl J Med, 375, pp. 754-766